drugset / Trial / NCT03071679
Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers
RandomizedFactorialQuadruple-blindOther
Summary
This study has a randomized, evaluator-blinded, vehicle- controlled study to assess the pharmacodynamics of omiganan and omiganan with imiquimod in healthy volunteers.
Timeline
- Start
- 2017-02-06
- Primary completion
- 2017-03-07
- Completion
- 2017-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imiquimod | Other / unclassified | 15 mg | Topical |
| Subject | Omiganan | Protein / enzyme biologic | 1 % | Topical |
| Subject | Omiganan | Protein / enzyme biologic | 2.5 % | Topical |
Indications
No indication recorded.